Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Jun 15;141(3):918–926.e3. doi: 10.1016/j.jaci.2017.05.028

Figure 1.

Figure 1

(A) SP-A expression as detected by Western blot is significantly decreased in obese asthma (OA) as compared to lean asthma (LA) (#p=0.002) and lean normal (LN) (*p=0.014) subjects. (B) SP-A levels are negatively correlated with increasing BMI, R= −0.33, p=0.013. (C) Representative Western blot of lean normal (LN), lean asthma (LA), obese normal (ON) and obese asthma (OA) samples. (D) SP-A levels measured via ELISA in a subset of samples demonstrate similar trends among groups (p=0.034).